Yasemin ÖZSÜREKÇİ, Özlem TEKŞAM, Ümit Murat ŞAHİNER, Elif Nursel ÖZMERT, Mehmet CEYHAN

COVID-19 Pandemic Experience in a Tertiary Care Center in Turkey: What have We Learned?

Coronavirus disease 2019 (COVID-19) has become a public health threat to people all over the world and it has stretched hospital resources since the beginning of the pandemic. Available reports to date showed that COVID-19 seems to be less common in children. However, the number of pediatric patients is increasing and a lower number of pediatric patients does not necessarily mean that children are less susceptible to the infection. On the other hand, it is shown that preparedness and response to the COVID-19 disease pandemic in the hospital caring for children are extremely variable. The main target during a pandemic is to maintain high quality and high-efficiency care, with emphasis on patient and provider safety. A documented pandemic plan, simulation training, appropriate use of personal protective equipment (PPE), and appropriate isolation areas in the hospital and also in the emergency department are essential components of pandemic response. Therefore, respiratory hygiene, proper patient placement/ isolation, handling and cleaning of patient care equipment, devices, and environment and procedure safety are all important for effective working flow and reliable working environment in the hospital. Early recognition and isolation of a patient with COVID-19 may help decrease exposure to the other patients and healthcare personnel. The use of a strict surveillance and management protocol during outbreaks of highly virulent viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), through dedicated patient pathways, adoption of personal protective equipment for health care personnel, and use of nasopharyngeal screening of all admitted children and possibly all healthcare personnel should be recommended. Therefore, we developed a protocol addressing reception, risk management, and hospitalization of suspected SARS-CoV-2 cases at the pediatric emergency department, pediatric wards, and outpatient clinics aimed at containing intrahospital transmission of the infection. Our pandemic response planning was characterized by close collaboration among the head of our hospital, department of pediatrics, pediatric emergency department, pediatric infection control committee, and front-line staff as well as optimization of communication channels. In this article, we aimed to share our experiences of how to handle pediatric patients with COVID-19 in our university hospital from all aspects including prevention of possible transmissions during the first few months of the COVID-19 pandemic

PDF

___

[1] Zhu N, Zhang D, Wang W et al. A novel coronavirus from patients with pneumonia in China, 2019. N Eng J Med 2020; 382:727-33. https://doi.org/10.1056/NEJMoa2001017
[2] World Health Organization. Statement on the second meeting of the International Health Regulations (2005), Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). WHO 2020; Geneva, Switzerland
[3] Li Q, Guan X, Wu P et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382: 1199-207. https://doi.org/10.1056/ NEJMoa2001316
[4] Guan WJ, Ni ZY, Hu Y et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med 2020; 382: 1708-20. https://doi.org/10.1056/NEJMoa2002032
[5] Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239-42. https://doi. org/10.1001/jama.2020.2648
[6] World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Data last updated: 2020/7/15 [Accessed 15 July 2020]. Available from: https:// covid19.who.int/?gclid= Cj0KCQjw0rr4BRCtARIsAB0_ 4 8 O 1 h m 7 k U R P W 4 O K a V Q x 9 F 1 F C y k s _ lcFXag9q6ZFJqBxrdJnL5my6EcgaAo- IEALw_wcB
[7] Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and better prognosis than adults. Acta Paediatr 2020;109: 1088-95. https://doi.org/10.1111/ apa.15270
[8] Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A, Nocerino A, et al. SARS-COV-2 in children and newborns: a systematic review. Eur J Pediatr 2020 May 18: 1-18. https:// doi.org/10.21203/rs.3.rs-24629/v1
[9] Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al- Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71-6. https://doi. org/10.1016/j.ijsu.2020.02.034
[10] Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 2020; 323: 1610-2. https://doi.org/10.1001/ jama.2020.3227
[11] van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS- CoV-1. N Engl J Med 2020; 382: 1564-7. https://doi.org/10.1056/ NEJMc2004973
[12] Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. Med Virol 2020: 92: 680-2. https://doi.org/10.1002/jmv.25742
[13] Shen KL, Yang YH, Jiang RM, et al. Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition). World J Pediatr 2020 April 24: 1-8.
[14] Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and Outcomes of Children with Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr 2020; 174: 868-73. https://doi. org/10.1001/jamapediatrics.2020.1948
[15] Devrim İ, Bayram N. Infection control practices in children during COVID-19 pandemic: differences from adults. Am J Infect Control 2020; 48: 933-9. https://doi.org/10.1016/j. ajic.2020.05.022
[16] Kluytmans M, Buiting A, Pas S, et al. SARS-CoV-2 infection in 86 healthcare workers in two Dutch hospitals in March 2020. medRxiv 2020; published online March 31.
[17] Reusken CB, Buiting A, Bleeker-Rovers C, et al. Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020. Euro Surveill 2020; 25: 2000334. https://doi.org/10.2807/1560-7917. ES.2020.25.12.2000334
[18] Centers for Disease Control and Prevention. Transmission- Based Precautions. Accessed 5 June 2020. https://www. cdc.gov/infectioncontrol/basics/transmission-basedprecautions. html.
[19] World Health Organization. Getting your workplace ready for COVID-19. Updated in March 3, 2020. Accessed 5 June 2020. https://www.who.int/docs/default-source/ coronaviruse/getting-workplace-ready-for-covid-19.pdf
[20] Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier enclosure during endotracheal intubation. N Eng J Med 2020; 383: 1957-8. https://doi.org/10.1056/ NEJMc2007589
[21] Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS ONE 2012: 7: e35797. https://doi. org/10.1371/journal.pone.0035797
[22] Rebmann T, Alexander S, Bartley J, Cain T, Citarella B, Cloughessy M, et al. APIC Position Paper: Extending the Use and/or Reusing Respiratory Protection in Healthcare Settings During Disasters.
[23] Centers for Disease Control and Prevention. Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings. Accessed 5 June 2020. https://www.cdc.gov/niosh/topics/ hcwcontrols/recommendedguidanceextuse.html
[24] Coronavirus Scientific Advisory Board (Turkey). Last update: 14 April 2020. Accessed 16 April 2020. https:// covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_ Rehberi.pdf
[25] Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA 2020; 323: 1843-4. https://doi.org/10.1001/ jama.2020.3786
[26] Marty FM, Chen K, Verrill KA. How to Obtain a Nasopharyngeal Swab Specimen. N Engl J Med 2020; 382: e76. https://doi.org/10.1056/NEJMvcm2010260
[27] Yang Y, Yang M, Shen C, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. 2020. https://doi.org/10.1101/2020.02.11.20021493
[28] Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SRAS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020; 71: 2027-34. https://doi. org/10.1093/cid/ciaa344
[29] Dong Y, Mo X, Hu Y et al. Epidemiology of COVID-19 Among Children in China. Pediatrics 2020; 145: e20200702. https://doi.org/10.1542/peds.2020-0702
[30] Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020; 295: 202-7. https://doi.org/10.1148/radiol.2020200230
[31] Mayo PH, Copetti R, Feller-Kopman D, et al. Thoracic ultrasonography: a narrative review. Intensive Care Med. 2019; 45: 1200-11. https://doi.org/10.1007/s00134-019- 05725-8
[32] Lomoro P, Verde F, Zerboni F, et al. COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review. Eur J Radiol Open 2020; 7: 100231. https://doi.org/10.1016/j. ejro.2020.100231
[33] Poggiali E DA, Bastoni D, et al. Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus (COVID-19) Pneumonia? Radiology 2020 March 13: 200847. https://doi.org/10.1148/radiol.2020200847
[34] Peng QY, Wang XT, Zhang LN, Chinese Critical Care Ultrasound Study G. Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic. Intensive Care Med 2020; 46: 849-50. https:// doi.org/10.1007/s00134-020-05996-6
[35] Denina M, Scolfaro C, Silvestro E, et al. Lung Ultrasound in Children With COVID-19. Pediatrics 2020; 146: e20201157. https://doi.org/10.1542/peds.2020-1157
[36] Long B, Brady W, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020; 38: 1504-7. https://doi.org/10.1016/j.ajem.2020.04.048 [37] Belhadjer Z, Meot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation 2020: 142: 429- 36. https://doi.org/10.1161/CIRCULATIONAHA.120.048360 [38] Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID 19 patients: Risk factors, predictors, and complications: A review. Journal of Cardiac Surgery. 2020 Apr 19 [Epub ahead of print]. https://doi.org/10.1111/ jocs.14538 [39] Slawinski G, Lewicka E. What should a cardiologist know about coronavirus disease 2019? Kardiol Pol 2020; 78: 278- 83. https://doi.org/10.33963/KP.15302 [40] Centers for Disease Control and Prevention. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Updated June 2, 2020. Accessed June 5, 2020. https://www.cdc. gov/coronavirus/2019-ncov/hcp/clinical-guidancemanagement- patients.html [41] World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. Updated March 13, 2020. Accessed March 20, 2020. https://apps.who.int/iris/handle/10665/331446?search-re sult=true&query=10665%2F331446&scope=&rpp=10&so rt_by=score&order=desc [42] Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). JAMA 2020; 323: 1824-36. https://doi. org/10.1001/jama.2020.6019 [43] NIH. Potential Antiviral Drugs Under Evaluation for the Treatment of COVID-19. Updated May 12, 2020. Accessed June 5, 2020. https://www.covid19treatmentguidelines. nih.gov/antiviral-therapy/ [44] Ong JSM, Tosoni A, Kim Y, Kisson N, Murthy S. Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of Literature. Pediatr Crit Care Med 2020; 21: 662-6. https:// doi.org/10.1097/PCC.0000000000002376 [45] Song W, Li J, Zou N et al. Clinical features of pediatric patients with coronavirus disease (COVID-19). J Clin Virol 2020; 127: 104377. https://doi.org/10.1016/j. jcv.2020.104377 [46] Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 2020; 382: 1787-99. https://doi.org/10.1056/ NEJMoa2001282